Uro oncology

Details

Title

Uro oncology

Type

Stage Two

Module code

HPS316

Requirement

Compulsory

Module objective

By the end of this module the Clinical Scientist in HSST will be able to critically analyse and synthesise their understanding of uro-oncology. The Clinical Scientist in HSST will be expected to apply their knowledge in the clinical setting and demonstrate the initial clinical assessment of the patient presenting with symptoms suggestive of urological malignancy. They will also be able to recognise the presence of underlying malignant disease in patients sent for tests of lower urinary tract function whilst critically evaluating their own response to both normal and complex situations using the professional attributes and insights required of a Consultant Clinical Scientist.

Knowledge and understanding

By the end of this module the Clinical Scientist in HSST will be able to critically analyse, synthesise and critically apply their expert knowledge with respect to uro-oncology including the:

• clinical presentation of the various urological malignancies, and understand the possibility of detecting these conditions through tests of physiological function including:
  • bladder outlet obstruction secondary to prostatic malignancy.
  • overactive bladder symptoms or recurrent urinary tract infections secondary to bladder cancer.
  • pelvic pain secondary to bladder or prostate cancer.
• epidemiology, risk factors and where applicable the genetic basis where applicable of the urological malignancies.
• investigation/management pathway for suspected urological malignancies, and recognise the need to expedite the investigation of the patient.

Technical and clinical skills

By the end of this module the Clinical Scientist in HSST will be expected to critically reflect and apply in practice a range of clinical, scientific and communication skills to advise and communicate effectively with patients, relevant clinicians and other healthcare professionals and will:

• recognise urological red flag symptoms.
• reflect on the challenges of applying research to practice in relation to these areas of practice and suggest improvements, building on a critique of available evidence.

Attitudes and behaviours

By the end of this module the Clinical Scientist in HSST will be expected to evaluate their own response to both normal and complex situations demonstrating the professional attributes and insights required of a Consultant Clinical Scientist consistently working within the limits of professional competence referring as appropriate to senior staff and will:

• work in partnership with patients where malignant disease is suspected, and recognise the need to involve healthcare professionals with appropriate counselling skills and background knowledge.
• maintain the highest standards of professional behaviour including a prioritisation of the patient’s dignity during intimate examinations.
• work within personal limitations and know when to ask for help, especially with regard to clinical issues.
• use effective judgement and decision-making skills.
• work effectively in a multi-disciplinary team and demonstrate leadership where appropriate.
• manage time and prioritise workload e.g. balance urgent and important demands.
• comply with ethical principles, safety, confidentiality and consent.
• be committed to and support continuous improvement of urodynamic services, with particular reference to auditing practice, evidence based practice, innovation, new and improved technologies.